Developing the EPA guidance of pharmacological treatment of schizophrenia – results of a Delphi process

Abstract Background The development of guidelines is time-consuming and cost-intensive. The heterogeneity of clinical practice, evidence, and patients’ needs is an issue across Europe. An European core guidance for a specific psychiatric disorder may help to overcome this issue. Here, we present a...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Peter Falkai, Elias Wagner, Miriam John, Vladislav Yakimov, Silvana Galderisi, Istvan Bitter, Geert Dom, Andrea Schmitt, Wolfgang Gaebel, Bernardo Carpiniello, Alkomiet Hasan
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Cambridge University Press 2025-01-01
coleção:	European Psychiatry
Assuntos:	Schizophrenia Guideline Europe Treatment Antipsychotics
Acesso em linha:	https://www.cambridge.org/core/product/identifier/S0924933824017942/type/journal_article
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!